Pharmaceutical intermediates
Rilzabrutinib Intermediates
3 pharmaceutical intermediates for Rilzabrutinib. Indication: Idiopathic thrombocytopenic purpura.
About Rilzabrutinib
- Originator
- Principia Biopharma Inc
- Indication
- Idiopathic thrombocytopenic purpura
- DS/DP
- 09/06/2033
Available intermediates
3 intermediates currently listed for Rilzabrutinib. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (2-fluoro-4-phenoxyphenyl)boronic acid | 1414356-30-1 | / | / |
| 3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine | 151266-23-8 | / | / |
| Benzyl 4-(oxetan-3-yl)piperazine-1-carboxylate | 1254115-22-4 | / | / |
Other programs under R
Building toward Rilzabrutinib?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →